Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Kremer: Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis:.... (0.14 sec) 

Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a …

- annals.org [PDF] 
JM Kremer, HK Genant, LW Moreland, AS … - Annals of internal medicine, 2006 - Am Coll Physicians
Background: The selective co-stimulation modulator abatacept demonstrated
efficacy for treating rheumatoid arthritis in early clin- ical studies. ...
Objective: To evaluate the effects of abatacept in patients with ...
Cited by 207 - Related articles - BL Direct - All 6 versions

Abatacept for rheumatoid arthritis refractory to tumor necrosis factor {alpha} inhibition

- medscape.com [PDF] 
MC Genovese, JC Becker, M Schiff, M Luggen, … - New England Journal of Medicine, 2005 - content.nejm.org
From Stanford University Medical Center, Stanford, Calif. (MCG); Bristol-Myers
Squibb, Princeton, NJ (J.-CB, KN, IN, TL, RA, DTH); the Denver Arthritis Clin-
ic, Denver (MS); the University of Cincin- nati Medical Center, Cincinnati ...
Cited by 361 - Related articles - BL Direct - All 11 versions

Safety of the selective costimulation modulator abatacept in rheumatoid arthritis patients …


M Weinblatt, B Combe, A Covucci, R Aranda, … - Arthritis Care & Research - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 122 - Related articles - BL Direct - All 3 versions

Selective costimulation modulation using abatacept in patients with active rheumatoid …


M Weinblatt, M Schiff, A Goldman, J Kremer, … - British Medical Journal, 2007 - ard.bmj.com
Results: A total of 121 patients were randomised; 80 completed double-blind
treatment and entered the LTE. During double-blind treatment, the difference in
the percentage of patients achieving the primary end point (modified ...
Cited by 75 - Related articles - BL Direct - All 5 versions

Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: …


JM Kremer, M Dougados, P Emery, P Durez, J … - Arthritis Care & Research - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 201 - Related articles - BL Direct - All 3 versions

Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double- …


LW Moreland, R Alten, F Van Den Bosch, T … - Arthritis Care & Research - interscience.wiley.com
T cells are involved in the pathogenesis of rheumatoid arthritis (RA). In animal
models of autoimmune diseases, blockade of costimulatory molecules on
antigen-presenting cells has been demonstrated to be effective in ...
Cited by 199 - Related articles - BL Direct - All 3 versions

Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi- …

- nih.gov
M Schiff, M Keiserman, C Codding, S … - British Medical Journal, 2008 - ard.bmj.com
Results: Similar patient demographics and clinical characteristics were present
at baseline between groups, with mean scores of 1.7 for HAQ-DI and 6.8 for DAS28
(ESR). At 6 months, mean changes in DAS28 (ESR) were significantly greater ...
Cited by 49 - Related articles - All 9 versions

Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of …


SB Cohen, P Emery, MW Greenwald, M … - Arthritis Care & Research - interscience.wiley.com
Dr. Cohen has received honoraria (less than $10,000 each) from Genentech, Biogen
Idec, Scios, and Amgen. Dr. Emery has received honoraria (less than $10,000)
from Genentech. Dr. Furie has received honoraria (less than $10,000 each) ...
Cited by 287 - Related articles - BL Direct - All 5 versions

The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite …


P Emery, R Fleischmann, A Filipowicz- … - Arthritis Care & Research - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 206 - Related articles - BL Direct - All 3 versions

Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion …

- umh.es [PDF] 
JM Kremer, R Westhovens, M Leon, E Di … - The New England journal of medicine, 2003 - nejm.highwire.org
Background Effective new therapies are needed for rheumatoid arthritis. Current
therapies target the products of activated macrophages; however, T cells also
have an important role in rheumatoid arthritis. A fusion protein — ...
Cited by 508 - Related articles - BL Direct - All 10 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google